Literature DB >> 32362491

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020).

Shibo Jiang, Christopher Hillyer, Lanying Du.   

Abstract

Entities:  

Year:  2020        PMID: 32362491     DOI: 10.1016/j.it.2020.04.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


× No keyword cloud information.
  33 in total

1.  Capillary whole-blood IgG-IgM COVID-19 self-test as a serological screening tool for SARS-CoV-2 infection adapted to the general public.

Authors:  Serge Tonen-Wolyec; Raphael Dupont; Salomon Batina-Agasa; Marie-Pierre Hayette; Laurent Bélec
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

2.  Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV.

Authors:  Laleh Sharifi; Amir Reza Safdarian; Pooya Farhangnia; Mahzad Akbarpour; Mahdis Borjkhani; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses.

Authors:  Sham Nambulli; Yufei Xiang; Natasha L Tilston-Lunel; Linda J Rennick; Zhe Sang; William B Klimstra; Douglas S Reed; Nicholas A Crossland; Yi Shi; W Paul Duprex
Journal:  Sci Adv       Date:  2021-05-26       Impact factor: 14.136

4.  The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.

Authors:  Bryan E Jones; Patricia L Brown-Augsburger; Kizzmekia S Corbett; Kathryn Westendorf; Julian Davies; Thomas P Cujec; Christopher M Wiethoff; Jamie L Blackbourne; Beverly A Heinz; Denisa Foster; Richard E Higgs; Deepa Balasubramaniam; Lingshu Wang; Yi Zhang; Eun Sung Yang; Roza Bidshahri; Lucas Kraft; Yuri Hwang; Stefanie Žentelis; Kevin R Jepson; Rodrigo Goya; Maia A Smith; David W Collins; Samuel J Hinshaw; Sean A Tycho; Davide Pellacani; Ping Xiang; Krithika Muthuraman; Solmaz Sobhanifar; Marissa H Piper; Franz J Triana; Jorg Hendle; Anna Pustilnik; Andrew C Adams; Shawn J Berens; Ralph S Baric; David R Martinez; Robert W Cross; Thomas W Geisbert; Viktoriya Borisevich; Olubukola Abiona; Hayley M Belli; Maren de Vries; Adil Mohamed; Meike Dittmann; Marie I Samanovic; Mark J Mulligan; Jory A Goldsmith; Ching-Lin Hsieh; Nicole V Johnson; Daniel Wrapp; Jason S McLellan; Bryan C Barnhart; Barney S Graham; John R Mascola; Carl L Hansen; Ester Falconer
Journal:  Sci Transl Med       Date:  2021-04-05       Impact factor: 19.319

5.  Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.

Authors:  Alberto L Garcia-Basteiro; Gemma Moncunill; Marta Tortajada; Marta Vidal; Caterina Guinovart; Alfons Jiménez; Rebeca Santano; Sergi Sanz; Susana Méndez; Anna Llupià; Ruth Aguilar; Selena Alonso; Diana Barrios; Carlo Carolis; Pau Cisteró; Eugenia Chóliz; Angeline Cruz; Silvia Fochs; Chenjerai Jairoce; Jochen Hecht; Montserrat Lamoglia; Mikel J Martínez; Robert A Mitchell; Natalia Ortega; Nuria Pey; Laura Puyol; Marta Ribes; Neus Rosell; Patricia Sotomayor; Sara Torres; Sarah Williams; Sonia Barroso; Anna Vilella; José Muñoz; Antoni Trilla; Pilar Varela; Alfredo Mayor; Carlota Dobaño
Journal:  Nat Commun       Date:  2020-07-08       Impact factor: 14.919

6.  Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection.

Authors:  Serena Marchi; Simonetta Viviani; Edmond J Remarque; Antonella Ruello; Emilio Bombardieri; Valentina Bollati; Gregorio P Milani; Alessandro Manenti; Giulia Lapini; Annunziata Rebuffat; Emanuele Montomoli; Claudia M Trombetta
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

Review 7.  Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.

Authors:  Gunawan Widjaja; Abduladheem Turki Jalil; Heshu Sulaiman Rahman; Walid Kamal Abdelbasset; Dmitry O Bokov; Wanich Suksatan; Mahnaz Ghaebi; Faroogh Marofi; Jamshid Gholizadeh Navashenaq; Farhad Jadidi-Niaragh; Majid Ahmadi
Journal:  Hum Immunol       Date:  2021-07-01       Impact factor: 2.850

8.  Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.

Authors:  Min Zhao; Pei-Yi Su; Danielle A Castro; Therese N Tripler; Yingxia Hu; Matthew Cook; Albert I Ko; Shelli F Farhadian; Benjamin Israelow; Charles S Dela Cruz; Yong Xiong; Richard E Sutton
Journal:  PLoS Pathog       Date:  2021-06-24       Impact factor: 7.464

Review 9.  The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.

Authors:  Lea Skak Filtenborg Frederiksen; Yibang Zhang; Camilla Foged; Aneesh Thakur
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

10.  Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein.

Authors:  Anna Z Wec; Daniel Wrapp; Andrew S Herbert; Daniel Maurer; Denise Haslwanter; Mrunal Sakharkar; Rohit K Jangra; M Eugenia Dieterle; Asparouh Lilov; Deli Huang; Longping V Tse; Nicole V Johnson; Ching-Lin Hsieh; Nianshuang Wang; Juergen H Nett; Elizabeth Champney; Irina Burnina; Michael Brown; Shu Lin; Melanie Sinclair; Carl Johnson; Sarat Pudi; Robert Bortz; Ariel S Wirchnianski; Ethan Laudermilch; Catalina Florez; J Maximilian Fels; Cecilia M O'Brien; Barney S Graham; David Nemazee; Dennis R Burton; Ralph S Baric; James E Voss; Kartik Chandran; John M Dye; Jason S McLellan; Laura M Walker
Journal:  bioRxiv       Date:  2020-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.